0P000013VJ

Defense, Oil Shares Rise, European Bourses Sag on Gulf War

BioMarin Says US FDA Approves Application for Rare Metabolic Disorder Treatment in Adolescents

President Capital Adjusts PT on Robinhood Markets to $98.60 From $179, Maintains Buy Rating

Update: Market Chatter: Paramount Skydance-Warner Bros Deal Likely to Win Easy EU Approval

BTIG Adjusts Price Target on CrowdStrike Holdings to $499 From $640, Maintains Buy Rating